Twoxar Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Twoxar Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11039
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Twoxar Inc (Twoxar) is an artificial intelligence-driven drug discovery company that develops novel drug candidates. The company’s drug discovery technology platform evaluates public and proprietary datasets to identify high probability drug-disease matches based on orders of magnitude. Its research programs include gene expression, protein-interaction, chemical structure, MOA, and clinical data, among others. The company also offers unbiased predictions that are based on statistical modelling. It builds pipeline of therapeutic candidates through collaborations with biotechnology and pharmaceutical companies. Twoxar is headquartered in Palo Alto, California, the US.

Twoxar Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Twoxar Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Twoxar Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Twoxar Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Twoxar Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Twoxar Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Twoxar Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
twoXAR Raises USD10 Million in Series A Venture Financing 10
twoXAR Raises USD3.4 Million in Seed Financing 11
twoXAR Secures Seed Funding 12
Partnerships 13
Adynxx and twoXAR Enter into Development Agreement 13
Santen Enters into Research Agreement with twoXAR 14
twoXAR Enters into Agreement with Icahn School of Medicine at Mount Sinai 15
twoXAR Enters into Agreement with Stanford University School of Medicine 16
twoXAR Enters into Research Agreement with University of Chicago Department of Medicine 17
twoXAR Enters into Research Agreement with Stanford University 18
Twoxar Inc – Key Competitors 19
Twoxar Inc – Key Employees 20
Twoxar Inc – Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Corporate Communications 22
Nov 27, 2017: twoXAR Announces Formation of Business Advisory Board 22
May 15, 2017: twoXAR Appoints Brian Moriarty as CFO and Jill Jene, PhD, as SVP, Business Development 23
Apr 10, 2017: twoXAR Appoints Distinguished Researchers to New Scientific Advisory Board 24
Clinical Trials 25
Jun 19, 2017: twoXAR Announces Preclinical Proof-of-Concept Data on Type 2 Diabetes Candidate 25
Other Significant Developments 26
Jun 28, 2017: MIT Startup Exchange Names twoXAR to STEX25 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Twoxar Inc, Pharmaceuticals & Healthcare, Key Facts 2
Twoxar Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Twoxar Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Twoxar Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Twoxar Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Twoxar Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
twoXAR Raises USD10 Million in Series A Venture Financing 10
twoXAR Raises USD3.4 Million in Seed Financing 11
twoXAR Secures Seed Funding 12
Adynxx and twoXAR Enter into Development Agreement 13
Santen Enters into Research Agreement with twoXAR 14
twoXAR Enters into Agreement with Icahn School of Medicine at Mount Sinai 15
twoXAR Enters into Agreement with Stanford University School of Medicine 16
twoXAR Enters into Research Agreement with University of Chicago Department of Medicine 17
twoXAR Enters into Research Agreement with Stanford University 18
Twoxar Inc, Key Competitors 19
Twoxar Inc, Key Employees 20

List of Figures
Twoxar Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Twoxar Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Twoxar Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Twoxar Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Twoxar Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Twoxar Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Twoxar Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Twoxar Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Twoxar Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hindalco Industries Ltd:企業の戦略・SWOT・財務情報
    Hindalco Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Hindalco Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Commercial Bank Of Kuwait Sak
    Commercial Bank Of Kuwait Sak - Strategy, SWOT and Corporate Finance Report Summary Commercial Bank Of Kuwait Sak - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Safe Orthopaedics SA (SAFOR):医療機器:M&Aディール及び事業提携情報
    Summary Safe Orthopaedics SA (Safe Orthopaedics) is medical device company that manufactures and markets devices for spinal surgery. The company’s products comprise implants and surgical instruments. It offers modular cervical cages, percutaneous auto-correction screws, modular anchorage screws, per …
  • PYCTX Ltd (PYC):企業の財務・戦略的SWOT分析
    Summary PYCTX Ltd (PYCTX), formerly Phylogica Ltd is a biotechnology company that develops intracellular biological therapeutics. The company utilizes proprietary phylomer peptide libraries and screening methodologies to identify unique peptide drug candidates. Its products include libraries and pep …
  • Exosome Diagnostics Inc:企業の製品パイプライン分析
    Summary Exosome Diagnostics Inc (Exosome Diagnostics) is a provider of diagnostic solutions. The company develops, designs, manufactures and markets biofluid-based molecular diagnostic tests and products for use in personalized medicine. Exosome Diagnostics’ services comprise miRNA profiling, mRNA p …
  • Knopp Biosciences LLC-製薬・医療分野:企業M&A・提携分析
    Summary Knopp Biosciences LLC (Knopp Biosciences) is a drug discovery and development company that develops and markets medicines for the treatment of neurological disorders. The company's lead product candidate, dexpramipexole, is an orally bioavailable small molecule which is used for the treatmen …
  • Seagate Technology Public Limited Company:企業のM&A・事業提携・投資動向
    Seagate Technology Public Limited Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Seagate Technology Public Limited Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detaile …
  • Frequency Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Frequency Therapeutics Inc (Frequency Therapeutics) is a biotechnology company that develops progenitor cell activation (PCA) therapies. The company’s small molecule drugs are used to activate progenitor cells for restoration of healthy tissue. Its lead program FX-322 is used to recreate sen …
  • B&N Bank (Joint-Stock Company):企業の戦略・SWOT・財務情報
    B&N Bank (Joint-Stock Company) - Strategy, SWOT and Corporate Finance Report Summary B&N Bank (Joint-Stock Company) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • MEDICREA Group (ALMED):医療機器:M&Aディール及び事業提携情報
    Summary MEDICREA Group (MEDICREA) is a medical equipment company that provides surgical solutions to neurosurgeons and orthopedic surgeons. The company designs, manufactures and distributes proprietary technologies related to patient specific spinal surgery. It offers products such as polyaxial spin …
  • ITOCHU Corporation:企業の戦略・SWOT・財務情報
    ITOCHU Corporation - Strategy, SWOT and Corporate Finance Report Summary ITOCHU Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Thales Deutschland GmbH:企業の戦略・SWOT・財務情報
    Thales Deutschland GmbH - Strategy, SWOT and Corporate Finance Report Summary Thales Deutschland GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Burger-In Oy:企業の戦略・SWOT・財務分析
    Burger-In Oy - Strategy, SWOT and Corporate Finance Report Summary Burger-In Oy - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Futura Medical Plc (FUM):製薬・医療:M&Aディール及び事業提携情報
    Summary Futura Medical Plc (Futura Medical) is a pharmaceutical company that focuses on research and development of novel products for various therapeutic areas, including sexual health and pain relief management. The company focuses on developing pharmaceutical products based on its transdermal dru …
  • CEL-SCI Corp (CVM):製薬・医療:M&Aディール及び事業提携情報
    Summary CEL-SCI Corp (CEL-SCI) is a biotechnology company that carries out the research and development of new immunotherapy products for the treatment of various cancer and infectious diseases. Its core capabilities include drug discovery, research, development and manufacturing of compound biologi …
  • Cellmid Ltd (CDY):企業の財務・戦略的SWOT分析
    Summary Cellmid Ltd (Cellmid) formerly Medical Therapies Ltd, is a life sciences company that develops and commercializes diagnostic and therapeutic products. The company holds comprehensive portfolio of intellectual property relating to the novel targets midkine and FGF5. It offers products such as …
  • Bionik Laboratories Corp (BNKL):医療機器:M&Aディール及び事業提携情報
    Summary Bionik Laboratories Corp (Bionik) is a medical device company that designs and develops transformational technologies, prosthetics and assisted robotic products and solutions. The company provides rehabilitation technology that senses patient movements and limitations. It provides lower body …
  • The Providence Service Corporation:企業の戦略・SWOT・財務情報
    The Providence Service Corporation - Strategy, SWOT and Corporate Finance Report Summary The Providence Service Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Xped Ltd (XPE):電力:M&Aディール及び事業提携情報
    Summary Xped Ltd (Xped) formerly Raya Group Limited, is an Internet of Things company that develops software and hardware solutions. It offers auto discovery remote control, Xerts, and Xped app software; and hardware such as Xped ADRC Shields, Umbo-Xped ADRC Hub, UltraPlug, VariPlug, IRBlaster. The …
  • Inoviem Scientific SAS-製薬・医療分野:企業M&A・提携分析
    Summary Inoviem Scientific SAS (Inoviem) is a contract research biotechnology company that offers preclinical and clinical services. The company develops solutions in the field of drug target interaction analysis and drug development. Its technologies include physiological intermolecular modulation …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆